Procter & Gamble Company (PG) fair value: what the stock is really worth
As of Nov 5, 2026: fair value (intrinsic value) of Procter & Gamble Company stock $118, price $167, that is 29.6% below the price, quality 75 out of 100. Rating: overvalued. Calculated from audited financials with 22 of our 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.
How to read this chart
60‑month range $111.44 – $171.26 · fair‑value band $76.71 – $149.79 · the $167.10 price screens above the $117.66 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.
Follow Procter & Gamble in your weekly email
Every Wednesday you see whether Procter & Gamble is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments.
Show moreShow less
The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands.
It also provides blades, razors, shave products, appliances, and other grooming products under the Braun, Gillette, and Venus brands.
In addition, the company offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brands; and gastrointestinal, pain relief, rapid diagnostics, respiratory, vitamins/minerals/supplements, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands.
Further, it provides fabric enhancers, and laundry additives and detergents under the Ariel, Downy, Gain, and Tide brands; and air and dish care, P&G professional, and surface care under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands.
Additionally, the company offers baby wipes, and taped diapers and pants under the Luvs and Pampers brands; adult incontinence and menstrual care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands.
It sells its products through mass merchandisers, social and e-commerce channels, grocery and specialty beauty stores, membership club stores, drug and department stores, distributors, wholesalers, airport duty-free and high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers.
The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.
Stock analysis
Procter & Gamble Company (PG) currently trades at $167.10, while our model-based Fair Value estimate is $117.66, 30% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of $117.66 per share, and 0 of the 22 models we run sit above the $167.10 price.
Bear case: the Economic Profit group reads lowest at $50.85, and 22 of the 22 models stay below the price. Data coverage for this calculation is high.
Scenario range: $76.71 (bear) to $149.79 (bull), the price of $167.10 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 75/100 (high quality), in the Consumer Defensive sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Procter & Gamble Company reported revenue of $87.0B in FY2026 versus $80.2B in FY2022, a compound +2.1%/yr. Reported net income was $16.0B in FY2026, compounding +2.1%/yr from FY2022.
Key figures
Market cap $405B Mega · P/E ratio 25.2 · P/S ratio 4.60 · EPS (TTM) $6.64 · Dividend yield 2.6% · Net margin 18.2% · Return on equity 29.6% · Return on assets (EBIT) 15.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 89 out of 100 (medium confidence).
What moves the price
The share trades at its 52-week high and 24% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −42% fair-value upside, at −30%, PG screens cheaper than that median.
Fair Value models
Bear$76.71Fair Value $117.66Bull$149.79
Price $167.10 · Downside -29.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 4 months old). Earnings retained since then ($0.8302 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
In the last 6 months, 12 officers or directors sold shares worth $32.0M and none bought.
SaleAndre SchultenChief Financial Officer4× since Nov 10, 2025: 42,941 shares, avg. $160.54$6.9MNov 4, 2026
SaleMatthew W. JanzarukSVP - Chief Accounting Officer3× since Aug 20, 2026: 9,994 shares, avg. $162.06$1.6MNov 3, 2026
SaleSundar G. RamanCEO-Fabric Home & Habitat Care2× since Aug 21, 2026: 41,688 shares, avg. $163.19$6.8MOct 30, 2026
SaleMoses Victor Javier AguilarChf Rsch, Dev & Innov Officer4× since Feb 13, 2026: 40,087 shares, avg. $160.47$6.4MOct 30, 2026
SalePaul GamaCEO- Health Care4× since Aug 20, 2026: 12,846 shares, avg. $154.73$2.0MOct 30, 2026
SaleBalaji PurushothamanChief Human Resources Officer3× since Feb 11, 2026: 19,027 shares, avg. $158.64$3.0MOct 23, 2026
SaleShailesh JejurikarChairman, President and CEO, Director2× since Aug 20, 2026: 41,176 shares, avg. $160.19$6.6MOct 23, 2026
SaleSusan Street WhaleyChief Legal Officer & Secy4× since Feb 19, 2026: 15,060 shares, avg. $146.04$2.2MOct 5, 2026
SaleMarc S. PritchardChief Brand Officer2× since Jan 23, 2026: 99,933 shares, avg. $150.85$15.1MAug 20, 2026
SaleFreddy P. BharuchaCEO - Beauty246 shares at $143.79$35,372Aug 20, 2026
Plus 5 more entries from the last 12 months.
Plus 47 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.73/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+3.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.7%
Start year 2021 (pandemic). Over 10 years: +2.9% a year
Revenue growth 40 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.4%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+6.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+3.8%
Dividend (yield on the price)2.6%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.3.8% vs 6.0%, steady
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.24% → 23%
Pace: the 5-year rate starts in 2021 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+9.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+3.0%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +7.2% a year for the price and +0.6% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (100 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Neutral
Recent news coverage is roughly neutral, about typical for how stocks are covered.
AI conclusion: Durable brand moat supported by pricing strength and scale underpins resilience in staples, yet input cost pressures keep margins under strain despite productivity savings.
Main risk: AI-native direct-to-consumer startups could use machine learning to offer customized hair care and laundry products that bypass traditional retail and reduce demand for P&G brands such as Head & Shoulders, Pantene and Tide.
Bull case: P&G could integrate AI for faster personalized formulation and targeted marketing while strengthening retailer partnerships to limit private-label encroachment and sustain premium positioning.
Bear case: If AI-driven customization and retailer private labels accelerate, P&G could lose meaningful share in beauty and home care categories, compressing margins as consumers shift to lower-priced or tailored alternatives.
P&G posted broad-based organic sales growth in its latest quarter, with gains across every category and region coming from higher volumes and better mix. Input cost pressures have increased and margins remain under strain even after productivity savings. Our models currently see it as overvalued. Will the recent product innovations and market share improvements deliver enough to offset rising costs, or will they leave profitability squeezed?
Compare Procter & Gamble Company with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 232 stocks
Beats the industry median on 5/14 measures
Overall it trails its industry peers.
Valuation
Quality Score75 · Top 25%
Fair Value upside−29.6% · Below median
Profitability
Return on equity (12 months)29.6% · Top 25%
Return on assets12.7% · Top 25%
Net margin (12 months)18.2% · Top 25%
Operating margin (12 months)27.1% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)4.0% · Below median
Dividend yield (12 months)2.6% · Below median
Balance sheet
Debt / equity0.42× · Highest 25%
Valuation Multiplesvs Household & Personal Products median · lower = cheaper
P/E (12 months)25.2× · Pricier than median
P/B7.45× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months)4.60× · Priciest 25%
Price / free cash flow (fiscal year)26.7× · Pricier than median
EV/EBITDA16.7× · Pricier than median
PEG4.11× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 33
FUTURE (revenue growth)20· sector 21
PAST (return on equity)100· sector 31
HEALTH (low debt)79· sector 98
DIVIDEND (yield)51· sector 53
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Procter & Gamble Company Fair Value". https://www.fairvalue-calculator.com/stock/PG
Frequently asked questions
Is Procter & Gamble Company (PG) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of $117.66 versus a price of $167.10, about 30% lower (overvalued).
What is the fair value of PG?
Our model-based fair value for Procter & Gamble Company is $117.66 (as of Nov 5, 2026), built from audited fundamentals. The current price: $167.10.
What is the quality score of PG?
Procter & Gamble Company has a Quality Score of 75/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Procter & Gamble Company (PG)?
Our model-based price target is the fair value of $117.66 (as of Nov 5, 2026) from 22 valuation models. Cautious scenario $76.71, optimistic scenario $149.79. It is a calculation from audited fundamentals, not an analyst target.
What is the Procter & Gamble Company stock forecast for 2026?
Our models put fair value at $117.66, about 30% lower versus a price of $167.10 (overvalued). Cautious scenario $76.71, optimistic scenario $149.79. The calculation is refreshed regularly with new filings.
What is the revenue of Procter & Gamble Company (PG)?
Procter & Gamble Company reported trailing-twelve-month revenue of about $87.9B (latest available figure, as of Nov 5, 2026).
Does Procter & Gamble Company pay a dividend?
Procter & Gamble Company currently shows a dividend yield of 2.57% relative to its recent price (as of Nov 5, 2026).
What growth is priced into Procter & Gamble Company (PG)?
For today's price to be fair in a discounted-cash-flow model, Procter & Gamble Company would have to grow free cash flow by +9.8 % per year for five years (discount rate 7.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +2.7 % per year. As of Nov 5, 2026.
What discount rate (WACC) does the fair value of PG use?
Our models discount Procter & Gamble Company at 7.6 %: a base by market capitalisation (mega), damped by beta 0.38, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Procter & Gamble Company that is +9.8 % per year a year over ten years, using the same discount rate (7.6 %) and the same formula as our fair value.
How much growth has Procter & Gamble Company (PG) delivered so far?
Over the past 5 years revenue at Procter & Gamble Company grew +2.7 % a year. The price currently implies +9.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Procter & Gamble Company (PG) growing?
The median revenue growth in the sector is +3.6 % a year. That is the yardstick for the growth priced into Procter & Gamble Company (+9.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Procter & Gamble Company (PG)?
The free-cash-flow yield on the price is 3.74 %: that much free cash flow Procter & Gamble Company produces per unit of market value. When it exceeds the discount rate of our models (7.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Procter & Gamble Company (PG)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Procter & Gamble Company it is $117.66 per share (as of Nov 5, 2026), against a price of $167.10. It is the blended result of 22 valuation models (cash flow, earnings, asset, dividend).
Is Procter & Gamble Company stock overvalued or undervalued in 2026?
As of Nov 5, 2026, PG trades above its calculated fair value: price $167.10, fair value $117.66, a gap of about −30% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PG?
No. The price is what the market pays today ($167.10); the fair value is what the company's own numbers justify ($117.66). For Procter & Gamble Company the two are $49.44 per share apart. That gap is exactly why we show both numbers side by side.
How much is Procter & Gamble Company worth?
The market values Procter & Gamble Company at about $405B (market capitalisation, as of Nov 5, 2026). Per share that is $167.10; our models calculate a fair value of $117.66 per share.
What do the bullish and bearish scenarios say about PG?
Our models span a range for Procter & Gamble Company: cautious scenario $76.71, base $117.66, optimistic $149.79 per share (as of Nov 5, 2026, price $167.10). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of PG?
Procter & Gamble Company trades at a price-to-earnings ratio of 25.2 (as of Nov 5, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $117.66 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2017 to 2026), reported earnings, FY2026 ex one-offs: 24.5. Other multiples: PEG 4.1, P/B 7.5, P/S 4.6, EV/EBITDA 16.7.
What is the PEG ratio of PG?
The PEG ratio of Procter & Gamble Company is 4.11 (P/E divided by earnings growth, as of Nov 5, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Procter & Gamble Company (PG)?
Balance-sheet figures for Procter & Gamble Company (as of Nov 5, 2026): return on equity 29.6%, debt of 0.42 per unit of equity. They feed the Quality Score of 75/100, which measures business quality independently of the share price.
How far is PG from its 52-week high?
Procter & Gamble Company trades at $167.10, at its 52-week high of $167.32 and 24% above the low of $135.03 (as of Nov 5, 2026). Distance from the high says nothing about value: that is what the fair value of $117.66 is for.
Which stocks are comparable to Procter & Gamble Company?
From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, The Estée Lauder Companies Inc, Kimberly-Clark Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Procter & Gamble Company stock attractive at the current price?
The data as of Nov 5, 2026: price $167.10, calculated fair value $117.66 (−30%), Quality Score 75/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PG calculated?
We run Procter & Gamble Company through 22 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $117.66, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.5% above its aggregate fair value. Procter & Gamble Company itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Procter & Gamble Company (PG)?
The closing price on Nov 5, 2026 was $167.10. Our model-based fair value is $117.66, about 30% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Procter & Gamble Company right now?
A high-quality business (quality 75/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. The price sits above even our optimistic bull case ($149.79). The favourable scenario is already priced in. A fairly wide model range ($76.71 to $149.79) leaves room in how you read the outcome.
Where does the earnings growth of Procter & Gamble Company (PG) come from?
Earnings per share at Procter & Gamble Company grew +5.7 % a year from 2015 to 2026. Broken into its drivers: revenue per share +4.3 %, EBIT margin +2.1 %, tax rate +0.2 %, residual (interest, one-offs) −1.0 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Procter & Gamble Company
How large is the market capitalisation of Procter & Gamble Company (PG)?
The market capitalisation of Procter & Gamble Company is $405B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Procter & Gamble Company (PG)?
The price-to-sales ratio of Procter & Gamble Company is 4.60 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Procter & Gamble Company (PG)?
Earnings per share at Procter & Gamble Company are $6.64 (price ÷ EPS = P/E 25.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Procter & Gamble Company (PG)?
The dividend yield of Procter & Gamble Company is 2.6% (payout 64.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Procter & Gamble Company (PG)?
The net margin of Procter & Gamble Company is 18.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Procter & Gamble Company (PG)?
The return on equity (ROE) of Procter & Gamble Company is 29.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Procter & Gamble Company (PG)?
On an EBIT basis the return on assets of Procter & Gamble Company is 15.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Procter & Gamble Company (PG)?
The operating margin of Procter & Gamble Company is 27.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Procter & Gamble Company (PG)?
Revenue at Procter & Gamble Company is growing +4.0% versus a year earlier (3y avg +2.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Procter & Gamble Company (PG)?
Earnings per share at Procter & Gamble Company are growing +0.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Procter & Gamble Company (PG) carry?
The net debt of Procter & Gamble Company is $25.1B (fiscal year 2026, ≈ 1.7 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Procter & Gamble Company in the live analysis
One click puts Procter & Gamble Company on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 5, 2026